Thomas B. Ottoboni
Chief Tech/Sci/R&D Officer bei HERON THERAPEUTICS, INC.
Profil
Thomas B.
Ottoboni is currently the Chief Scientific Officer & SVP-Pharmaceutical at Heron Therapeutics, Inc. He previously worked as the Director-Drug Delivery at Vitaphore Corp.
from 1992 to 1994, Manager-Systems Development at InSite Vision, Inc. from 1994 to 1996, and Chief Operating Officer at POINT Biomedical Corp.
from 1996 to 2008.
He also served as the Vice President-Research & Development at Talima Therapeutics, Inc. from 2010 to 2011.
Dr. Ottoboni obtained his undergraduate degree in 1981 and his doctorate degree in 1986 from the University of California, Berkeley.
Aktive Positionen von Thomas B. Ottoboni
| Unternehmen | Position | Beginn |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30.03.2012 |
Ehemalige bekannte Positionen von Thomas B. Ottoboni
| Unternehmen | Position | Ende |
|---|---|---|
Talima Therapeutics, Inc.
 Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA. | Chief Tech/Sci/R&D Officer | 01.01.2011 |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Chief Operating Officer | 01.07.2008 |
| INSITE VISION INC. | Corporate Officer/Principal | 01.07.1996 |
| Vitaphore Corp. | Corporate Officer/Principal | 01.01.1994 |
Ausbildung von Thomas B. Ottoboni
| University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
Talima Therapeutics, Inc.
Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA. | Health Technology |
| Vitaphore Corp. |
